🇫🇷 Tradjenta in France

Tradjenta (LINAGLIPTIN) regulatory status in France.

Marketing authorisation

ANSM

  • Local brand name: Trajenta
  • Status: approved

Tradjenta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in France

Frequently asked questions

Is Tradjenta approved in France?

Yes. ANSM has authorised it.

Who is the marketing authorisation holder for Tradjenta in France?

Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.